TB/HIV co-infections up 40% across Europe over the last five years
New data released today by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe ahead of World TB Day show that new tuberculosis cases and deaths in the 53 countries of the WHO European Region declined each year by 4.3% and 8.5% respectively between 2011 and 2015. However, vulnerable groups for TB infection, such as people living with HIV, prisoners and migrants, do not benefit from this overall trend. In particular, new TB/HIV co-infections increased by 40% over the same time period.
Drug-resistant Tuberculosis continues to spread: new report. Concern about childhood TBArchived
A new report, Tuberculosis surveillance in Europe 2009, a joint publication from ECDC and the WHO Regional Office for Europe to mark World Tuberculosis Day 2011, provides evidence for concern about the spread of multi-drug resistant tuberculosis (MDR TB) and the persistence of TB among children.
New ECDC-WHO report: tuberculosis on the retreat in Europe. Concerns about drug-resistant TB and treatment failureArchived
To mark World Tuberculosis Day on 24 March 2012, the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe publish their joint report, Tuberculosis surveillance and monitoring in Europe 2012.
Towards TB elimination: ECDC and ERS introduce new guidelines on tuberculosis care in EuropeArchived
ECDC and the European Respiratory Society (ERS) have developed 21 patient-centred standards that aim to guide clinicians and public health workers in their daily work to ensure optimal diagnosis, treatment and prevention of tuberculosis (TB) in Europe. Nearly 74 000 reported TB cases in the EU/EEA in 2010 clearly show that tuberculosis remains a public health challenge across the region.
Adequate treatment essential to stop TB across Europe – new ECDC/WHO report
Over 1 000 patients are estimated to fall sick with tuberculosis (TB) every day across Europe – or more than 380 000 yearly – signalling that there is no room for complacency when it comes to TB prevention and control.
Press release: 4% annual decrease too slow to end TB by 2030 – call for Europe’s commitment to increase investment to end TB
A new report published today by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe indicates that the number of new tuberculosis (TB) patients has been decreasing at an average rate of 4.3% per year in the WHO European Region over the last decade.
Tuberculosis cases down by 5% each year but Europe fails to cure majority of multidrug-resistant patients
Across the 53 countries of the WHO European Region, an estimated 353 000 patients fell sick with tuberculosis (TB) in 2012, according to new data published by the European Centre for Disease Prevention and Control and the WHO Regional Office for Europe. The data show an average annual 5% decline in TB incidence across the Region over the last decade. Since 2011, the countries of the European Union and European Economic Area (EU/EEA) observed a 6% decrease in TB cases with 68 000 reported cases in 2012. Overall, the EU/EEA countries met their target of an average five-year decline. However, Europe has not yet met the set targets for successful treatment of multidrug-resistant TB.
TB elimination at stake unless Europe takes urgent care of the most vulnerable including the poor, the marginalised and migrants
New data released by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe ahead of World TB Day show that an estimated 340 000 Europeans developed tuberculosis (TB) in 2014, corresponding to a rate of 37 cases per 100 000 population.
Every hour 30 people are diagnosed with tuberculosis in the European Region. It’s time to make TB a disease of the past
The latest ECDC/WHO report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region.